Ketotreat Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement designed to support patients with chronic kidney disease (CKD) by providing essential amino acid precursors without contributing to nitrogenous waste accumulation. This formulation aids in the management of protein-energy malnutrition commonly observed in CKD by supplying ketoanalogues of essential amino acids, which are transaminated in the body to form amino acids, thereby reducing the nitrogen load on compromised kidneys. Ketotreat is typically administered as an adjunct to a low-protein diet to help maintain nutritional status while minimizing uremic symptoms and delaying the progression of renal impairment. The tablet is indicated for use in patients with moderate to severe renal insufficiency who require dietary protein restriction but need to prevent malnutrition. It is important to use Ketotreat under medical supervision, with regular monitoring of renal function and nutritional parameters. Contraindications include hypersensitivity to any component of the formulation. Common adverse effects are rare but may include gastrointestinal discomfort. Ketotreat Tablet should be stored in a cool, dry place away from direct sunlight. Its use contributes to improved quality of life and clinical outcomes in CKD management by optimizing protein metabolism and reducing the metabolic burden on the kidneys.